Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
Uclventures, Albion
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2026 Formerly Epilepsygtx (epilepsygtx.com)
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Focalis Bio is developing precision gene therapies to treat focal refractory epilepsy and help patients achieve seizure freedom.